Does INFLIXIMAB-DYYB Cause Product use issue? 1,116 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 1,116 reports of Product use issue have been filed in association with INFLIXIMAB-DYYB (ZYMFENTRA). This represents 4.4% of all adverse event reports for INFLIXIMAB-DYYB.
1,116
Reports of Product use issue with INFLIXIMAB-DYYB
4.4%
of all INFLIXIMAB-DYYB reports
38
Deaths
332
Hospitalizations
How Dangerous Is Product use issue From INFLIXIMAB-DYYB?
Of the 1,116 reports, 38 (3.4%) resulted in death, 332 (29.7%) required hospitalization, and 18 (1.6%) were considered life-threatening.
Is Product use issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for INFLIXIMAB-DYYB. However, 1,116 reports have been filed with the FAERS database.
What Other Side Effects Does INFLIXIMAB-DYYB Cause?
Off label use (14,256)
Condition aggravated (10,275)
Intentional product use issue (7,549)
Inappropriate schedule of product administration (5,977)
Arthralgia (4,615)
Drug ineffective (3,112)
Fatigue (3,111)
Weight increased (2,848)
Malaise (2,766)
Weight decreased (2,703)
What Other Drugs Cause Product use issue?
INFLIXIMAB (12,752)
DUPILUMAB (10,575)
POLYETHYLENE GLYCOL 3350 (9,432)
METHOTREXATE (8,185)
DICLOFENAC (8,009)
RITUXIMAB (6,948)
ADALIMUMAB (6,379)
ETANERCEPT (6,062)
TOCILIZUMAB (5,944)
ABATACEPT (5,915)
Which INFLIXIMAB-DYYB Alternatives Have Lower Product use issue Risk?
INFLIXIMAB-DYYB vs INFLIXIMAB-QBTX
INFLIXIMAB-DYYB vs INFLIXIMAB, RECOMBINANT
INFLIXIMAB-DYYB vs INFLUENZA A VIRUS A/CALIFORNIA/7/2009 LIVE ANTIGEN\INFLUENZA A VIRUS A/TEXAS/50/2012 LIVE ANTIGEN\INFLUENZA B VIRUS B/BRISBANE/60/2008 LIVE ANTIGEN\INFLUENZA B VIRUS B/MASSACHUSETTS/2/2012 LIVE ANTIGEN
INFLIXIMAB-DYYB vs INFLUENZA VIRUS VACCINE
INFLIXIMAB-DYYB vs INFLUENZA VIRUS VACCINE QUADRIVALENT TYPE A+B